CAPTRUST Financial Advisors’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$32.1K Buy
11,705
+847
+8% +$2.68K ﹤0.01% 2932
2025
Q4
$40.2K Buy
+10,858
New +$35.1K ﹤0.01% 2693
2024
Q1
Sell
-10,050
Closed -$30.1K 2311
2023
Q4
$30.1K Buy
+10,050
New +$13K ﹤0.01% 2610
2023
Q3
Sell
-10,102
Closed -$14K 2654
2023
Q2
$14K Buy
+10,102
New +$14.1K ﹤0.01% 2473
2022
Q3
Sell
-2,312
Closed -$15K 2666
2022
Q2
$15K Buy
2,312
+2,128
+1,157% +$12.1K ﹤0.01% 3532
2022
Q1
$1K Buy
184
+84
+84% +$360 ﹤0.01% 4684
2021
Q4
$0 Sell
100
-450
-82% -$3.6K ﹤0.01% 4807
2021
Q3
$7K Buy
550
+382
+227% +$5.56K ﹤0.01% 3800
2021
Q2
$4K Buy
168
+9
+6% +$217 ﹤0.01% 3943
2021
Q1
$4K Sell
159
-291
-65% -$8.59K ﹤0.01% 3801
2020
Q4
$12K Hold
450
﹤0.01% 2479
2020
Q3
$16K Sell
450
-100
-18% -$3.96K ﹤0.01% 2073
2020
Q2
$28K Buy
+550
New +$23K ﹤0.01% 1817

Other funds holding ESPR